Veloxis Drops as Danske Sees Astellas Threat: Copenhagen Mover

Veloxis Pharmaceuticals A/S, the Danish maker of a treatment for transplant patients, fell the most in more than two weeks in Copenhagen trading after Danske Bank A/S said its product faces increased competition.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.